Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background Little is known about the involvement of matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor TIMP-2 in multiple sclerosis (MS). Objective To elucidate the actual implication of MMP-2 and TIMP-2 in MS. Methods Cerebrospinal fluid (CSF) and serum levels of active MMP-2 and TIMP-2 were measured by activity assay system and ELISA, respectively, in 67 patients with relapsing–remitting MS (RRMS), categorized according clinical and magnetic resonance imaging (MRI), and in 129 controls. Results Cerebrospinal fluid and serum active MMP-2/TIMP-2 ratio mean values and an intrathecal active MMP-2 production were more increased in RRMS than in non-inflammatory conditions ( P < 0.001, P < 0.05, and P < 0.0001, respectively) and in MRI inactive than in MRI active RRMS ( P < 0.02, P < 0.01 and P < 0.001, respectively). An intrathecal synthesis of active MMP-2 was more frequent in RRMS than in inflammatory disorders ( P < 0.01). Serum active MMP-2/TIMP-2 ratio and MS disease duration were positively correlated ( P < 0.02). Conclusion These findings suggest a potential role for MMP-2 activity in the termination of MS neuroinflammation related to remission of the disease and seem to indicate that serum MMP-2/TIMP-2 ratio may represent a useful biomarker for monitoring MS recovery phase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582 · cited 3×
“Although intrathecally synthesized active MMP-2 predominates in MS patients, these data indicate that a local release within the CNS and an increase in CSF and serum levels of active MMP-2 are not restricted to MS, but are shared by several inflammatory neurological conditions confirming that MMP-2 is probably implica…”
BackgroundFainardi, E., Castellazzi, M., Bellini, T., Manfrinato, M. C., Baldi, E., Casetta, I., Paolino, E., Granieri, E., & Dallocchio, F. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1274oa · Cited by 145 · cited 1×
“This hypothesis seems to be confirmed by our recent data indicating that cerebrospinal fluid (CSF) mean levels and an intrathecal synthesis of active MMP-9 are increased more in MS than in some non-inflammatory conditions and are associated with MS inflammatory disease activity [4].”
ResultSelf-citation
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Gerwien, H., Hermann, S., Zhang, X., Korpos, E., Song, J., Kopka, K., Faust, A., Wenning, C., Gross, C. C., Honold, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8020 · Cited by 113
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger, K., Rivera, S., Liechti, F. D., Grandgirard, D., Bigas, J., Seco, J., Tarrago, T., Leib, S. L., & Khrestchatisky, M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00014-1 · Cited by 52
Škuljec, J., Gudi, V., Ulrich, R., Frichert, K., Yildiz, Ö., Pul, R., Voss, E. V., Wissel, K., Baumgärtner, W., & Stangel, M. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182294fad · Cited by 49
“In the serum and cerebrospinal fluid of the MS patients, decreased TIMP-1 and TIMP-2 levels as well as elevated MMP-9 and MMP-2 levels have been found, suggesting that high MMP-9/TIMP-1 and MMP2/TIMP2 ratios play an important role in the pathogenesis and progression of MS (44, 45).”
BackgroundTen years of proteomics in multiple sclerosis
Farias, A. S., Pradella, F., Schmitt, A., Santos, L. M. B., & Martins‐de‐Souza, D. (2014) · PROTEOMICS · doi:10.1002/pmic.201300268 · Cited by 40
Metadata
- Authors
- Fainardi, E., Castellazzi, M., Tamborino, C., Trentini, A., Manfrinato, M., Baldi, E., Tola, M., Dallocchio, F., Granieri, E., & Bellini, T.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2009-03-24
- Volume
- 15
- Issue
- 5
- Pages
- 547-554
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2098952232
- Cited by
- 33
- References
- 3
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis. https://app.cochat.ai/papers/10.1177/1352458509102372
- The paper
- Fainardi, E., Castellazzi, M., Tamborino, C., Trentini, A., Manfrinato, M., Baldi, E., Tola, M., Dallocchio, F., Granieri, E., & Bellini, T. (2009). Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458509102372
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.